Clinical trial
Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT
NCT00249093 is registered in ClinicalTrials.gov with LHL Helse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT
- Lead sponsor
- LHL Helse
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- April 30, 2007
- Enrollment
- 20
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd